The U.S. Food and Drug Administration has approved Insmed's daily bronchiectasis pill, brensocatib, which will be sold under ...

Cylembio is a therapeutic cancer vaccine candidate that targets cells and immune-suppressive cells in the tumor microenvironment through activation and expansion of T cells against IDO1 and/or PD-L1 ...

The HPV campaign’s success in Sindh will depend not only on logistics but also on addressing deep-rooted social inequities. A ...

Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in ...

Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in treatment for cancers, rare disease and more.

The National Health Service ( NHS) wants to eliminate cervical cancer by 2040, but says it needs to achieve a 90% vaccination ...

A new vaccine for pancreatic cancer has shown potential in early trials, slowing disease progression and increasing survival ...

A new experimental pancreatic cancer vaccine may help stop the disease from coming back. it targets common gene mutations found in about 90% of pancreatic cancers.

David Wallace-Wells and Emily Oster argue that the effects of MAHA will be long-lasting.

Pediatrician Deborah Greenhouse writes that South Carolina is at risk because of the U.S. government’s decision to defund almost $500 million in mRNA vaccine research funding.

When U.S. Sen. Bill Cassidy decided to cast a key vote to confirm Robert F. Kennedy Jr. as Secretary of Health and Human ...

Gastric cancer is one of the leading causes of cancer-related mortality worldwide, and peritoneal metastasis, wherein the cancer spreads to the peritoneum or the lining of the abdominal cavity, ...